Literature DB >> 18696112

The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin.

Mariska van Vliet1, Inès A von Rosenstiel, Roger K Schindhelm, Desiderius P M Brandjes, Jos H Beijnen, Michaela Diamant.   

Abstract

We studied the association between alanine aminotransferase (ALT) and features of the metabolic syndrome in a cohort of overweight and obese children aged 3-18 years. An oral glucose tolerance test was performed in 443 consecutive children from an obesity out-patient clinic (median age 11.2, range 3.1-18.0 years; n=240 boys) of multi-ethnic origin. The prevalence of the metabolic syndrome, insulin resistance, elevated ALT (>30 IU/L), and the association of ALT with (components of) the metabolic syndrome was assessed. The metabolic syndrome was present in 26.9%. Elevated ALT levels were found in 20.3%, with a higher prevalence in boys than in girls (25.8% versus 13.8%, P<0.001). ALT was associated with the prevalence of the metabolic syndrome, insulin resistance, high triglycerides, and low HDL-cholesterol after adjustment for gender, age, and BMI. In conclusion, elevated ALT levels were highly prevalent and associated with the metabolic syndrome, insulin resistance, high triglycerides, and low HDL-cholesterol in an obese multiethnic pediatric population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18696112     DOI: 10.1007/s00431-008-0802-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  29 in total

1.  Prevalence of the insulin resistance syndrome in obesity.

Authors:  R M Viner; T Y Segal; E Lichtarowicz-Krynska; P Hindmarsh
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

2.  Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.

Authors:  Dharmendrakumar A Patel; Sathanur R Srinivasan; Ji-Hua Xu; Wei Chen; Gerald S Berenson
Journal:  Metabolism       Date:  2007-06       Impact factor: 8.694

3.  Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Authors:  Christian Meyer; Walkyria Pimenta; Hans J Woerle; Timon Van Haeften; Ervin Szoke; Asimina Mitrakou; John Gerich
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

4.  Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.

Authors:  Roger K Schindhelm; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Coen D A Stehouwer; Robert J Heine; Michaela Diamant
Journal:  Atherosclerosis       Date:  2006-05-08       Impact factor: 5.162

Review 5.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Metabolic syndrome in Turkish children and adolescents.

Authors:  Mehmet Agirbasli; Servet Cakir; Sencan Ozme; Gonenc Ciliv
Journal:  Metabolism       Date:  2006-08       Impact factor: 8.694

8.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

9.  Waist circumference, blood pressure, and lipid components of the metabolic syndrome.

Authors:  SoJung Lee; Fida Bacha; Silva A Arslanian
Journal:  J Pediatr       Date:  2006-12       Impact factor: 4.406

10.  Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Alain G Bertoni; Nathan D Wong; Steven Shea; Shuangge Ma; Kiang Liu; Srikanthan Preethi; David R Jacobs; Colin Wu; Mohammed F Saad; Moyses Szklo
Journal:  Diabetes Care       Date:  2007-08-17       Impact factor: 19.112

View more
  14 in total

1.  Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Christine Carter-Kent; Michael Elias; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2011-06-01

2.  Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial.

Authors:  Ruth S Weinstock; Kimberly L Drews; Sonia Caprio; Natasha I Leibel; Siripoom Vudhipoom McKay; Philip S Zeitler
Journal:  Obesity (Silver Spring)       Date:  2015-06-05       Impact factor: 5.002

3.  Metabolic predictors for early identification of fatty liver using doppler and B-mode ultrasonography in overweight and obese adolescents.

Authors:  Mine Ozkol; Betül Ersoy; Erhun Kasirga; Fatma Taneli; Işil Esen Bostanci; Bayram Ozhan
Journal:  Eur J Pediatr       Date:  2010-05-25       Impact factor: 3.183

4.  Multidisciplinary therapy reduces risk factors for metabolic syndrome in obese adolescents.

Authors:  Josiane Aparecida Alves Bianchini; Danilo Fernandes da Silva; Claudia Christina Sanchez Nardo; Idalina Diair Regla Carolino; Florencio Hernandes; Nelson Nardo
Journal:  Eur J Pediatr       Date:  2012-10-25       Impact factor: 3.183

5.  Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adolescents.

Authors:  Roya Kelishadi; Stephen R Cook; Atoosa Adibi; Zahra Faghihimani; Shohreh Ghatrehsamani; Abolfazl Beihaghi; Hamidreza Salehi; Noushin Khavarian; Parinaz Poursafa
Journal:  Diabetol Metab Syndr       Date:  2009-12-22       Impact factor: 3.320

6.  Obesity and metabolic syndrome in 7-9 years-old Portuguese schoolchildren.

Authors:  Carla Pedrosa; Bruno Mpm Oliveira; Isabel Albuquerque; Carlos Simões-Pereira; Maria D Vaz-de-Almeida; Flora Correia
Journal:  Diabetol Metab Syndr       Date:  2010-06-10       Impact factor: 3.320

7.  Relationships of cardiorespiratory fitness with metabolic risk factors, inflammation, and liver transaminases in overweight youths.

Authors:  Dominique Bouglé; Gautier Zunquin; Bruno Sesbouë; Jean-Pierre Sabatier
Journal:  Int J Pediatr       Date:  2010-06-28

8.  Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children.

Authors:  Mariska van Vliet; Roel P Gazendam; Inès A von Rosenstiel; Anton P van Zanten; Desiderius P M Brandjes; Jos H Beijnen; Joost Rotteveel; Michaela Diamant
Journal:  Eur J Pediatr       Date:  2010-10-20       Impact factor: 3.183

9.  Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease.

Authors:  Roya Kelishadi; Parinaz Poursafa
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

10.  First National Report on Aminotransaminases' Percentiles in Children of the Middle East and North Africa (MENA): the CASPIAN-III Study.

Authors:  Roya Kelishadi; Seyed-Hossein Abtahi; Mostafa Qorbani; Ramin Heshmat; Mohammad Esmaeil Motlagh; Mahnaz Taslimi; Tahereh Aminaee; Gelayol Ardalan; Parinaz Poursafa; Payam Moin
Journal:  Hepat Mon       Date:  2012-11-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.